Therapeutics and COVID-19: living guideline [Internet]
- PMID: 35917393
- Bookshelf ID: NBK582436
Therapeutics and COVID-19: living guideline [Internet]
Excerpt
The WHO Therapeutics and COVID-19: living guideline contains the most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. It is available in pdf format (via the ‘Download’ button) and via an
The latest version (version 13, published 13 January 2023) contains important updates to recommendations which relate to:
** UPDATED ** the strong recommendation for the use of nirmatrelvir-ritonavir in patients with non-severe illness at the highest risk of hospitalization (published 22 April 2022, updated 13 January 2023) has been updated with new recommendation regarding use of nirmatrelvir-ritonavir during pregnancy and breastfeeding.
** UPDATED **the strong recommendation against the use of casirivimab-imdevimab in patients with COVID-19 (first published 24 September 2021, updated 03 March 2022, updated 16 Sept 2022, updated 13 January 2023) has been updated with new evidence of the reduction of effectiveness of casirivimab-imdevimab against circulating Omicron variants.
** UPDATED ** the strong recommendation against the use of sotrovimab in patients with non-severe COVID-19 (first published 14 January 2022, updated 16 Sept 2022, updated 13 January 2023) with new evidence of the reduction of effectiveness of sotrovimab against circulating Omicron variants.
Guidelines regarding the use of drugs to prevent (rather than treat) COVID-19 are included in a separate document, WHO Living guideline: Drugs to prevent COVID-19, that can be accessed via an
Guidelines regarding the clinical management of COVID-19 patients are included in a further document, COVID-19 Clinical management: Living guideline, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of
© World Health Organization 2021.
Similar articles
-
Drugs to prevent COVID-19: A WHO living guideline [Internet].Geneva: World Health Organization; 2021 Mar 2–. Geneva: World Health Organization; 2021 Mar 2–. PMID: 35917395 Free Books & Documents. Review.
-
Clinical management of COVID-19: Living guideline [Internet].Geneva: World Health Organization; 2022 Jun 23–. Geneva: World Health Organization; 2022 Jun 23–. PMID: 35917394 Free Books & Documents. Review.
-
Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (July 2022).Acute Med Surg. 2022 Oct 19;9(1):e789. doi: 10.1002/ams2.789. eCollection 2022 Jan-Dec. Acute Med Surg. 2022. PMID: 36267628 Free PMC article.
-
Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce.Med J Aust. 2022 Oct 3;217(7):368-378. doi: 10.5694/mja2.51718. Med J Aust. 2022. PMID: 36150213 Free PMC article.
-
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients.Ann Med. 2022 Dec;54(1):2856-2860. doi: 10.1080/07853890.2022.2133162. Ann Med. 2022. PMID: 36259490 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous